U.S. Medical Equipment Stock News

NYSE:PRO
NYSE:PROSoftware

Does PROS Holdings Offer Value After Expanding Its AI Pricing Capabilities in 2025?

Wondering if PROS Holdings at around $23 is a quietly mispriced opportunity or a value trap in disguise? You are not alone. This stock often flies under the radar despite operating in a high-potential niche of AI powered pricing and revenue optimization software. Over the last month the share price has inched up about 0.5%, contributing to an 8.2% gain year to date. However, that is still set against a rough 5 year journey that has left the stock down more than 50% from its earlier...
NasdaqGM:YDES
NasdaqGM:YDESBiotechs

Assessing YD Bio (YDES) Valuation After a Sharp One-Month Share Price Rebound

Market context and recent trading action YD Bio (YDES) has quietly turned heads after a sharp move over the past month, with the stock up roughly 43% even as its past 3 months performance remains deeply negative. See our latest analysis for YD Bio. That recent 1 month share price return of about 43% has only partially repaired earlier damage, leaving the 3 month share price return sharply negative even as the year to date share price return turns modestly positive. This suggests momentum is...
NasdaqCM:GNSS
NasdaqCM:GNSSCommunications

Genasys (GNSS) Q3: Deeper $6.5M Loss on $9.9M Revenue Reinforces Bearish Narratives

Genasys (GNSS) just posted its FY 2025 third quarter numbers, with revenue of about $9.9 million and a basic EPS loss of roughly $0.14, setting the stage for another closely watched update on its path toward profitability. The company has seen quarterly revenue move from about $5.7 million in Q2 FY 2024 to $6.7 million in Q4 FY 2024 and then to the current $9.9 million print in Q3 FY 2025. Over the same stretch, basic EPS has ranged from a $0.26 loss to the latest $0.14 loss, keeping margins...
NYSE:REVG
NYSE:REVGMachinery

REV Group (REVG) Margin Compression Reinforces Bearish Narrative Despite Solid EPS Growth

REV Group (REVG) just posted its FY 2025 third quarter numbers, with revenue at $644.9 million and basic EPS of about $0.60, alongside trailing twelve month revenue of roughly $2.4 billion and EPS of about $2.14. The company has seen quarterly revenue move from $579.4 million in FY 2024 Q3 to $644.9 million in FY 2025 Q3, while basic EPS has shifted from roughly $0.35 to $0.60 over the same stretch. This sets up a results season where investors are watching how much of that topline is...